Toward a unifying entity that encompasses most, but perhaps not all, inflammatory leiomyosarcomas and histiocyte-rich rhabdomyoblastic tumors

Mod Pathol. 2021 Jul;34(7):1434-1438. doi: 10.1038/s41379-021-00797-8. Epub 2021 Mar 24.

Jen-Chieh Lee¹, Wan-Shan Li^{2

3}, Yu-Chien Kao^{4

5}, Yung-Chuan Chung⁶, Hsuan-Ying Huang⁷

¹ Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. leejenchieh@ntuh.gov.tw.
² Department of Pathology, Chi-Mei Medical Center, Tainan, Taiwan.
³ Department of Medical Laboratory Science and Biotechnology, Chung Hwa University of Medical Technology, Tainan, Taiwan.
⁴ Department of Pathology, Shuang Ho Hospital, Taipei Medical University, Taipei, Taiwan.
⁵ Department of Pathology, School of Medicine, College of Medicine, Taipei Medical University, Taipei, Taiwan.
⁶ Department and Graduate Institute of Pathology, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan.
⁷ Department of Anatomic Pathology, Kaohsiung Chang Gung Memorial Hospital and Chang Gung University College of Medicine, Kaohsiung, Taiwan. a120600310@yahoo.com.

No abstract available

Publication types